Longboard Pharmaceuticals Inc (NASDAQ: LBPH) is 481.92% higher on its value in year-to-date trading and has touched a low of $3.60 and a high of $40.48 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LBPH stock was last observed hovering at around $35.75 in the last trading session, with the day’s loss setting it -0.66%.
Currently trading at $35.09, the stock is 0.48% and 12.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.51 million and changing -1.85% at the moment leaves the stock 72.83% off its SMA200. LBPH registered 489.75% gain for a year compared to 6-month gain of 63.36%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.15% loss in the last 1 month and extending the period to 3 months gives it a 77.85%, and is 0.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.16% over the week and 7.84% over the month.
Longboard Pharmaceuticals Inc (LBPH) has around 50 employees, a market worth around $1.37B and $0.00M in sales. Distance from 52-week low is 874.72% and -13.32% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.71%).
The EPS is expected to grow by 14.07% this year
162.0 institutions hold shares in Longboard Pharmaceuticals Inc (LBPH), with institutional investors hold 119.28% of the company’s shares. The shares outstanding are 38.90M, and float is at 33.46M with Short Float at 14.82%. Institutions hold 117.72% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.42 million shares valued at $119.34 million. The investor’s holdings represent 11.3559 of the LBPH Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 3.29 million shares valued at $88.9 million to account for 8.4596 of the shares outstanding. The other top investors are FARALLON CAPITAL MANAGEMENT LLC which holds 2.94 million shares representing 7.5629 and valued at over $79.48 million, while CORMORANT ASSET MANAGEMENT, LP holds 7.1771 of the shares totaling 2.79 million with a market value of $75.43 million.
Longboard Pharmaceuticals Inc (LBPH) Insider Activity
The most recent transaction is an insider purchase by Kaye Randall, the company’s CMO. SEC filings show that Kaye Randall bought 100 shares of the company’s common stock on Jan 23 ’24 at a price of $24.82 per share for a total of $2482.0. Following the purchase, the insider now owns 100.0 shares.
Longboard Pharmaceuticals Inc disclosed in a document filed with the SEC on Aug 12 ’24 that Kaye Randall (CMO) sold a total of 16,667 shares of the company’s common stock. The trade occurred on Aug 12 ’24 and was made at $34.73 per share for $0.58 million. Following the transaction, the insider now directly holds 17920.0 shares of the LBPH stock.
Still, SEC filings show that on Jun 25 ’24, Kaye Randall (CMO) disposed off 100 shares at an average price of $20.87 for $2087.0. The insider now directly holds 0 shares of Longboard Pharmaceuticals Inc (LBPH).
